Literature DB >> 24677231

Targeting activated platelets and fibrinolysis: hitting two birds with one stone.

Adili Reheman1, Xiaohong Xu, Emily C Reddy, Heyu Ni.   

Abstract

Keywords:  Editorials; blood platelets; fibrinolysis; thrombolytic therapy; thrombosis

Mesh：

Substances：

Year:  2014        PMID： 24677231     DOI： 10.1161/CIRCRESAHA.114.303600

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

1.  The integrin PSI domain has an endogenous thiol isomerase function and is a novel target for antiplatelet therapy.

Authors:  Guangheng Zhu; Qing Zhang; Emily C Reddy; Naadiya Carrim; Yunfeng Chen; Xiaohong Ruby Xu; Miao Xu; Yiming Wang; Yan Hou; Li Ma; Yan Li; Min Rui; Tania N Petruzziello-Pellegrini; Christopher Lavalle; Tyler W Stratton; Xi Lei; Reheman Adili; Pingguo Chen; Cheng Zhu; John A Wilkins; Richard O Hynes; John Freedman; Heyu Ni
Journal:  Blood       Date:  2017-01-25       Impact factor: 22.113

2.  Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke.

Authors:  Zhiye Zhang; Chuanbin Shen; Mingqian Fang; Yajun Han; Chengbo Long; Weihui Liu; Min Yang; Ming Liu; Dengdeng Zhang; Qiqi Cao; Xue Chen; Yaqun Fang; Qiumin Lu; Zongliu Hou; Yaxiong Li; Zhenze Liu; Xi Lei; Heyu Ni; Ren Lai
Journal:  Cell Mol Life Sci       Date:  2022-04-13       Impact factor: 9.261

Review 3.  Fibronectin maintains the balance between hemostasis and thrombosis.

Authors:  Yiming Wang; Heyu Ni
Journal:  Cell Mol Life Sci       Date:  2016-04-21       Impact factor: 9.261

4.  In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα.

Authors:  Benjamin Xiaoyi Li; Xiangrong Dai; Xiaohong Ruby Xu; Reheman Adili; Miguel Antonio Dias Neves; Xi Lei; Chuanbin Shen; Guangheng Zhu; Yiming Wang; Hui Zhou; Yan Hou; Tiffany Ni; Yfke Pasman; Zhongqiang Yang; Fang Qian; Yanan Zhao; Yongxiang Gao; Jing Liu; Maikun Teng; Alexandra H Marshall; Eric G Cerenzia; Mandy Lokyee Li; Heyu Ni
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 5.  Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies.

Authors:  Xiaohong Ruby Xu; Naadiya Carrim; Miguel Antonio Dias Neves; Thomas McKeown; Tyler W Stratton; Rodrigo Matos Pinto Coelho; Xi Lei; Pingguo Chen; Jianhua Xu; Xiangrong Dai; Benjamin Xiaoyi Li; Heyu Ni
Journal:  Thromb J       Date:  2016-10-04

6.  Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia.

Authors:  Brian Vadasz; Pingguo Chen; Issaka Yougbaré; Darko Zdravic; June Li; Conglei Li; Naadiya Carrim; Heyu Ni
Journal:  Genes Dis       Date:  2015-06-01

7.  Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis.

Authors:  Xiaohong Ruby Xu; Yiming Wang; Reheman Adili; Lining Ju; Christopher M Spring; Joseph Wuxun Jin; Hong Yang; Miguel A D Neves; Pingguo Chen; Yan Yang; Xi Lei; Yunfeng Chen; Reid C Gallant; Miao Xu; Hailong Zhang; Jina Song; Peifeng Ke; Dan Zhang; Naadiya Carrim; Si-Yang Yu; Guangheng Zhu; Yi-Min She; Terry Cyr; Wenbin Fu; Guoqing Liu; Philip W Connelly; Margaret L Rand; Khosrow Adeli; John Freedman; Jeffrey E Lee; Patrick Tso; Patrizia Marchese; W Sean Davidson; Shaun P Jackson; Cheng Zhu; Zaverio M Ruggeri; Heyu Ni
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

8.  Acupuncture treatment for carotid atherosclerotic plaques: study protocol for a pilot randomized, single blinded, controlled clinical trial.

Authors:  Junhe Zhou; Lin Zhao; Lingcui Meng; Huitao Liang; Ting Zhou; Siting Ye; Zhiqi Qi; Xichang Huang; Peng Zhou; Wenbin Fu
Journal:  Trials       Date:  2020-09-07       Impact factor: 2.279

Review 9.  Crosstalk Between Platelets and Microbial Pathogens.

Authors:  Conglei Li; June Li; Heyu Ni
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.